| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Rallis Chris A is a Director at FENNEC PHARMACEUTICALS INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $571K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 10, 2025 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE | 1,775 | $9.24 | $16,401.00 | -3.0% | -11.6% | - | |
| Jul 7, 2025 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE | 1,119 | $8.71 | $9,746.49 | -2.0% | +15.0% | - | |
| Apr 11, 2025 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE | 1,409 | $4.95 | $6,974.55 | -2.6% | +80.4% | +16.0% | |
| Feb 14, 2025 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE | 1,186 | $6.82 | $8,088.52 | -2.2% | -1.9% | +26.0% | |
| Dec 2, 2024 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE | 6,409 | $6.14 | $39,351.26 | -10.9% | +8.5% | +22.0% | |
| Oct 8, 2024 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE | 1,406 | $4.53 | $6,369.18 | -2.8% | +34.8% | +104.4% | |
| Jul 5, 2024 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE | 1,173 | $6.03 | $7,073.19 | -2.5% | -22.2% | +45.8% | |
| Apr 15, 2024 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE | 800 | $10.45 | $8,360.00 | -1.8% | -36.7% | -49.2% | |
| Mar 26, 2024 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE | 2,114 | $10.97 | $23,190.58 | -4.9% | -41.7% | -40.6% | |
| Dec 26, 2023 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE | 1,390 | $10.90 | $15,151.00 | -3.0% | -5.2% | -45.1% |